FECAL CALPROTECTIN AS A SURROGATE MARKER OF CLINICAL REMISSION, CLINICAL RESPONSE, ENDOSCOPIC IMPROVEMENT, AND HISTO-ENDOSCOPIC MUCOSAL HEALING: UNIFI INDUCTION STUDY

Brian G. Feagan  1     Reena Khanna  2     Colleen W. Marano  3     Hongyan Zhang  3     Bruce E. Sands  4    
1 Robarts Research Institute,London,Canada
2 University of Western Ontario,London,Canada
3 Janssen Research & Development, LLC,Spring House,United States
4 Icahn School of Medicine at Mount Sinai,New York,United States

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing